鉴别脑膜瘤WHO分级的影像评分系统
肿瘤体积≥36.0 cc和边缘不规则各计2分,瘤周水肿计1分;评分≥3分时预测II级脑膜瘤的召回率0.80、精确率0.73、F1分数0.77、准确率0.76、AUC 0.82。结论认为该评分系统具有良好预测能力,但需外部验证。
要点
- 评分≥3分提示WHO II级脑膜瘤可能性较高,应提示临床。
- 肿瘤体积≥36.0 cc和边缘不规则各2分,瘤周水肿1分。
- 评分0分时WHO II级概率为0%,需注意低分并不完全排除。
核心结论
- 所提出的影像评分系统对WHO II级脑膜瘤具有良好的预测能力,区分度和校准度较好,但需外部验证。
研究设计与样本
- 回顾术前MRI序列,根据统计和临床显著性选择影像特征,依据多因素分析beta系数赋分,总分0-5分。
关键影像表现/征象
- 肿瘤体积≥36.0 cc赋2分,肿瘤边缘不规则赋2分,瘤周水肿赋1分。
诊断标准与关键数值
- 评分0、1、2、3、≥4分对应的WHO II级脑膜瘤概率分别为0%、25.0%、38.5%、65.4%、83.3%。
- 以≥3分为阈值,召回率0.80、精确率0.73、F1分数0.77、准确率0.76、AUC 0.82。
临床应用与阅片要点
- 术前MRI评估脑膜瘤时,应测量肿瘤体积并注意≥36.0 cc、边缘不规则及瘤周水肿等特征。
- 评分≥3分时应在报告中提示WHO II级可能,建议结合临床进一步评估。
局限性
- 单中心回顾性研究,样本量有限,需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We sought to establish a comprehensive imaging score indicating the likelihood of higher WHO grade meningiomas pre-operatively.
METHODS: All surgical intracranial meningioma patients at our institution between 2014 and 2018 underwent retrospective chart review. Preoperative MRI sequences were reviewed, and imaging features were included in the score based on statistical and clinical significance. Point values for each significant feature were assigned based on the beta coefficients obtained from multivariate analysis. The imaging score was calculated by adding up the points, for a total score of 0 to 5. The predictive ability of the score to identify higher-grade meningiomas was evaluated.
RESULTS: Ninety patients, 50% of whom had a postoperative diagnosis of WHO grade II meningioma, were included. The mean age for the population was 59.9 years and 70% were female. Tumor volume ≥ 36.0 cc was assigned 2 points, presence of irregular tumor borders was assigned 2 points, and presence of peritumoral edema was assigned 1 point. The probability of having a WHO grade II meningioma was 0% with a score of 0, 25.0% with a score of 1, 38.5% with a score of 2, 65.4% with a score of 3, and 83.3% with a score of 4 or greater. A threshold of ≥ 3 points achieved a recall of 0.80, precision of 0.73, F1-score of 0.77, accuracy of 0.76, and AUC of 0.82.
CONCLUSION: The proposed imaging scoring system had good predictive capability for WHO grade II meningiomas with good discrimination and calibration. External validation is needed.
引用
- Funari, De la Garza Ramos, Cezayirli, et al. Imaging score for differentiation of meningioma grade. Neuroradiology. 2022. PMID: 36504373. doi:10.1007/s00234-022-03101-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。